Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Leigh syndrome is a subacute necrotizing encephalomyelopathy characterized by bilateral basal ganglia lesions and lactic acidosis. MT-ND1 encodes the NADH:ubiquinone oxidoreductase core subunit 1 of mitochondrial complex I. Pathogenic variants in MT-ND1 impair complex I activity, leading to energy failure in high-demand neural tissues, and have been repeatedly observed in Leigh syndrome patients.
Overall, the MT-ND1–Leigh syndrome association is classified as Strong. Multiple unrelated probands (n = 7) harboring pathogenic MT-ND1 variants have been described, including m.3685T>C (p.Tyr127His) and m.3928G>C (p.Val208Leu) in isolated cases ([PMID:9073033]; [PMID:24063851]). Three siblings homoplasmic for m.3697G>A (p.Gly131Ser) showed maternal segregation with complex I deficiency ([PMID:24830958]). Functional data from cybrid studies and respiratory assays consistently demonstrate complex I impairment concordant with the Leigh phenotype.
Inheritance of MT-ND1 variants follows maternal (mitochondrial) transmission. Segregation analysis in the m.3697G>A family revealed two additional affected siblings sharing the homoplasmic variant. Case series report at least seven probands with MT-ND1 missense and frameshift variants, all associated with autosomal-like recessive manifestations under maternal inheritance. The variant spectrum includes missense changes (e.g., m.3685T>C (p.Tyr127His), m.3928G>C (p.Val208Leu), m.3955G>A (p.Gly131Ser)), homoplasmic or high-heteroplasmy substitutions, and small insertions (e.g., m.3571_3572insC). No recurrent founder alleles have been identified, but m.8993T>G/C variants in MT-ATP6 often co-occur with ND1 dysfunction.
Pathogenic MT-ND1 variants disrupt complex I assembly and activity leading to decreased oxygen consumption, elevated lactate, and impaired ATP synthesis in patient cells and cybrids. For example, m.3685T>C cybrids exhibit reduced complex I function and de novo occurrence correlates with de novo disease ([PMID:35217561]). Cybrid rescue experiments confirm that wild-type MT-ND1 expression restores complex I assembly and normalizes bioenergetics. Animal or cellular models carrying MT-ND1 mutations reproduce key neuropathological features of Leigh syndrome.
No studies have convincingly refuted the MT-ND1–Leigh syndrome link. Variants in other complex I subunits and nuclear genes may produce overlapping phenotypes, but pathogenic MT-ND1 mutations consistently co-segregate with Leigh syndrome presentations.
MT-ND1 pathogenic variants cause maternal-inherited Leigh syndrome through haploinsufficiency of complex I. Genetic testing of MT-ND1 is recommended in patients with early-onset neurodegeneration, basal ganglia lesions, and lactic acidosis. Functional assays in patient-derived cells and cybrids support variant pathogenicity.
Key Take-home: MT-ND1 sequencing and heteroplasmy assessment are clinically useful for diagnosis and genetic counseling in Leigh syndrome.
Gene–Disease AssociationStrongSeven unrelated probands with diverse MT-ND1 variants and concordant functional data Genetic EvidenceStrongAt least seven probands in six families; multiple missense and frameshift variants; maternal segregation Functional EvidenceModerateCybrid and enzyme assays confirm complex I deficiency and rescue by wild-type MT-ND1 |